English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Preprint

Oligodendrocytes and neurons contribute to amyloid-β deposition in Alzheimer’s disease

MPS-Authors
/persons/resource/persons271994

Sasmita,  Andrew O.
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons289893

Nazarenko,  Taisiia
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons270577

Sun,  Ting
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons270575

Siems,  Sophie B.
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

Yu,  Xuan
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons182091

Böhler,  Carolin
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

Ong,  Erinne Cherisse
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

Wu,  Zoe
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons182382

Ruhwedel,  Torben
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons289897

Subramanian,  Swati
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

Börensen,  Friederike
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons289895

Overhoff,  Katharina
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons213399

Spieth,  Lena
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons202532

Berghoff,  Stefan A.
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons289899

Eggert,  Simone
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons182163

Goebbels,  Sandra
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons182306

Möbius,  Wiebke
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

/persons/resource/persons182320

Nave,  Klaus-Armin
Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
Supplementary Material (public)
There is no public supplementary material available
Citation

Sasmita, A. O., Depp, C., Nazarenko, T., Sun, T., Siems, S. B., Yu, X., et al. (2023). Oligodendrocytes and neurons contribute to amyloid-β deposition in Alzheimer’s disease. bioRxiv. doi:10.1101/2023.12.11.570514.


Cite as: https://hdl.handle.net/21.11116/0000-000E-3B96-7
Abstract
In Alzheimer’s disease (AD), amyloid-β (Aβ) is thought to be of neuronal origin. However, in single-cell RNAseq datasets from mouse and human, we found transcripts of amyloid precursor protein (APP) and the amyloidogenic-processing machinery equally abundant in oligodendrocytes (OLs). By cell-type-specific deletion of Bace1 in a humanized knock-in AD model, APPNLGF, we demonstrate that almost a third of cortical Aβ deposited in plaques is derived from OLs. However, excitatory projection neurons must provide a threshold level of Aβ production for plaque deposition to occur and for oligodendroglial Aβ to co-aggregate. Indeed, very few plaques are deposited in the absence of neuronally-derived Aβ, although soluble Aβ species are readily detected, especially in subcortical white matter. Our data identify OLs as a source of Aβ in vivo and further underscore a non-linear relationship between cellular Aβ production and resulting plaque formation. Ultimately, our observations are relevant for therapeutic strategies aimed at disease prevention in AD.